| Carrington Place Of St Pete | |
| 10501 Roosevelt Blvd N, Saint Petersburg, Florida 33716 | |
| (727) 577-3800 | |
| Name | Carrington Place Of St Pete |
|---|---|
| Location | 10501 Roosevelt Blvd N, Saint Petersburg, Florida |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 120 |
| Occupancy Rate | 75.92% |
| Medicare ID (CCN) | 105616 |
| Legal Business Name | Cplace Of St. Pete, Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1013963842 |
| Organization Name | CARRINGTON PLACE OF ST PETE, LLC |
| Doing Business As | CARRINGTON PLACE NURSING & REHABILITATION CENTER |
| Address | 10501 Roosevelt Blvd N, Saint Petersburg, FL 33716 |
| Phone Number | 727-577-3800 |
News Archive
New research published in the Journal of the International Society of Sports Nutrition suggests that eating raisins may provide the same workout boost as sports chews.
Noting that aid "has mixed impacts," Jonathan Glennie, a research fellow with the Overseas Development Institute, writes in the Guardian's "Poverty Matters Blog" that "there is one argument against aid that we need to tackle head on; the idea that we cannot afford aid, that we are being over-generous, especially in a time of cuts at home."
Genentech, Inc., a wholly-owned member of the Roche Group, today announced that the company submitted two supplemental Biologics License Applications (sBLAs) to the U.S. Food and Drug Administration (FDA) for Avastin® (bevacizumab) for the treatment of women who have not received chemotherapy for advanced (metastatic) HER2-negative breast cancer (first-line treatment). One sBLA is based on the Phase III study AVADO that investigated Avastin in combination with docetaxel chemotherapy.
Daiichi Sankyo Company, Ltd. and NGM Biopharmaceuticals, Inc. announced today that they have entered into a research collaboration and license agreement to discover and develop novel therapeutics that modulate beta-cell regeneration for the treatment of diabetes.
› Verified 2 days ago
| NPI Number | 1114217114 |
| Organization Name | CPLACE OF ST. PETE, LLC |
| Doing Business As | CARRINGTON PLACE OF ST. PETE |
| Address | 10501 Roosevelt Blvd N, St Petersburg, FL 33716 |
| Phone Number | 727-577-3800 |
News Archive
New research published in the Journal of the International Society of Sports Nutrition suggests that eating raisins may provide the same workout boost as sports chews.
Noting that aid "has mixed impacts," Jonathan Glennie, a research fellow with the Overseas Development Institute, writes in the Guardian's "Poverty Matters Blog" that "there is one argument against aid that we need to tackle head on; the idea that we cannot afford aid, that we are being over-generous, especially in a time of cuts at home."
Genentech, Inc., a wholly-owned member of the Roche Group, today announced that the company submitted two supplemental Biologics License Applications (sBLAs) to the U.S. Food and Drug Administration (FDA) for Avastin® (bevacizumab) for the treatment of women who have not received chemotherapy for advanced (metastatic) HER2-negative breast cancer (first-line treatment). One sBLA is based on the Phase III study AVADO that investigated Avastin in combination with docetaxel chemotherapy.
Daiichi Sankyo Company, Ltd. and NGM Biopharmaceuticals, Inc. announced today that they have entered into a research collaboration and license agreement to discover and develop novel therapeutics that modulate beta-cell regeneration for the treatment of diabetes.
› Verified 2 days ago
| NPI Number | 1184677676 |
| Organization Name | CANDANSK, LLC |
| Doing Business As | CARRINGTON PLACE NURSING & REHABILITATION CENTER |
| Address | 10501 Roosevelt Blvd N, Saint Petersburg, FL 33716 |
| Phone Number | 727-577-3800 |
News Archive
New research published in the Journal of the International Society of Sports Nutrition suggests that eating raisins may provide the same workout boost as sports chews.
Noting that aid "has mixed impacts," Jonathan Glennie, a research fellow with the Overseas Development Institute, writes in the Guardian's "Poverty Matters Blog" that "there is one argument against aid that we need to tackle head on; the idea that we cannot afford aid, that we are being over-generous, especially in a time of cuts at home."
Genentech, Inc., a wholly-owned member of the Roche Group, today announced that the company submitted two supplemental Biologics License Applications (sBLAs) to the U.S. Food and Drug Administration (FDA) for Avastin® (bevacizumab) for the treatment of women who have not received chemotherapy for advanced (metastatic) HER2-negative breast cancer (first-line treatment). One sBLA is based on the Phase III study AVADO that investigated Avastin in combination with docetaxel chemotherapy.
Daiichi Sankyo Company, Ltd. and NGM Biopharmaceuticals, Inc. announced today that they have entered into a research collaboration and license agreement to discover and develop novel therapeutics that modulate beta-cell regeneration for the treatment of diabetes.
› Verified 2 days ago
| NPI Number | 1447580519 |
| Organization Name | ALADDIN REHAB CENTER OF ST PETE LLC |
| Doing Business As | CARRINGTON PLACE |
| Address | 10501 Roosevelt Blvd N, St Petersburg, FL 33716 |
| Phone Number | 727-577-3800 |
News Archive
New research published in the Journal of the International Society of Sports Nutrition suggests that eating raisins may provide the same workout boost as sports chews.
Noting that aid "has mixed impacts," Jonathan Glennie, a research fellow with the Overseas Development Institute, writes in the Guardian's "Poverty Matters Blog" that "there is one argument against aid that we need to tackle head on; the idea that we cannot afford aid, that we are being over-generous, especially in a time of cuts at home."
Genentech, Inc., a wholly-owned member of the Roche Group, today announced that the company submitted two supplemental Biologics License Applications (sBLAs) to the U.S. Food and Drug Administration (FDA) for Avastin® (bevacizumab) for the treatment of women who have not received chemotherapy for advanced (metastatic) HER2-negative breast cancer (first-line treatment). One sBLA is based on the Phase III study AVADO that investigated Avastin in combination with docetaxel chemotherapy.
Daiichi Sankyo Company, Ltd. and NGM Biopharmaceuticals, Inc. announced today that they have entered into a research collaboration and license agreement to discover and develop novel therapeutics that modulate beta-cell regeneration for the treatment of diabetes.
› Verified 2 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
New research published in the Journal of the International Society of Sports Nutrition suggests that eating raisins may provide the same workout boost as sports chews.
Noting that aid "has mixed impacts," Jonathan Glennie, a research fellow with the Overseas Development Institute, writes in the Guardian's "Poverty Matters Blog" that "there is one argument against aid that we need to tackle head on; the idea that we cannot afford aid, that we are being over-generous, especially in a time of cuts at home."
Genentech, Inc., a wholly-owned member of the Roche Group, today announced that the company submitted two supplemental Biologics License Applications (sBLAs) to the U.S. Food and Drug Administration (FDA) for Avastin® (bevacizumab) for the treatment of women who have not received chemotherapy for advanced (metastatic) HER2-negative breast cancer (first-line treatment). One sBLA is based on the Phase III study AVADO that investigated Avastin in combination with docetaxel chemotherapy.
Daiichi Sankyo Company, Ltd. and NGM Biopharmaceuticals, Inc. announced today that they have entered into a research collaboration and license agreement to discover and develop novel therapeutics that modulate beta-cell regeneration for the treatment of diabetes.
› Verified 2 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 2 |
| Total Amount of Fines in Dollars | $32279 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 2 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 14.16 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 9.91 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 36.05 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 4.53 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 7.98 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0.75 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 1.89 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 92.83 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 25.2 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 77.23 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 3.59 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 15.8 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 25 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 12.24 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 80.51 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 23.69 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 72.28 | 82.93 |
News Archive
New research published in the Journal of the International Society of Sports Nutrition suggests that eating raisins may provide the same workout boost as sports chews.
Noting that aid "has mixed impacts," Jonathan Glennie, a research fellow with the Overseas Development Institute, writes in the Guardian's "Poverty Matters Blog" that "there is one argument against aid that we need to tackle head on; the idea that we cannot afford aid, that we are being over-generous, especially in a time of cuts at home."
Genentech, Inc., a wholly-owned member of the Roche Group, today announced that the company submitted two supplemental Biologics License Applications (sBLAs) to the U.S. Food and Drug Administration (FDA) for Avastin® (bevacizumab) for the treatment of women who have not received chemotherapy for advanced (metastatic) HER2-negative breast cancer (first-line treatment). One sBLA is based on the Phase III study AVADO that investigated Avastin in combination with docetaxel chemotherapy.
Daiichi Sankyo Company, Ltd. and NGM Biopharmaceuticals, Inc. announced today that they have entered into a research collaboration and license agreement to discover and develop novel therapeutics that modulate beta-cell regeneration for the treatment of diabetes.
› Verified 2 days ago
Shore Acres Care Center Location: 4500 Indianapolis St Ne, Saint Petersburg, Florida 33703 Phone: (727) 527-5801 | |
Lexington Health And Rehabilitation Center Location: 6300 46th Ave N, Saint Petersburg, Florida 33709 Phone: (727) 544-1444 | |
South Heritage Health & Rehabilitation Center Location: 718 Lakeview Ave S, Saint Petersburg, Florida 33705 Phone: (727) 894-5125 | |
North Rehabilitation Center Location: 1301 16th St N, Saint Petersburg, Florida 33705 Phone: (727) 822-3171 | |
Apollo Health And Rehabilitation Center Location: 1000 24th St N, Saint Petersburg, Florida 33713 Phone: (727) 323-4711 |